Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results.
Kereiakes, Dean J
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. [electronic resource] - Circulation Sep 2003 - 1310-5 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
1524-4539
10.1161/01.CIR.0000087602.91755.19 doi
Adult
Angioplasty, Balloon, Coronary
Combined Modality Therapy
Coronary Angiography
Coronary Artery Disease--diagnostic imaging
Dose-Response Relationship, Drug
Dose-Response Relationship, Radiation
Female
Follow-Up Studies
Humans
Infusions, Intravenous
Male
Metalloporphyrins--administration & dosage
Middle Aged
Photochemotherapy--adverse effects
Photosensitizing Agents--administration & dosage
Stents
Treatment Outcome
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. [electronic resource] - Circulation Sep 2003 - 1310-5 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
1524-4539
10.1161/01.CIR.0000087602.91755.19 doi
Adult
Angioplasty, Balloon, Coronary
Combined Modality Therapy
Coronary Angiography
Coronary Artery Disease--diagnostic imaging
Dose-Response Relationship, Drug
Dose-Response Relationship, Radiation
Female
Follow-Up Studies
Humans
Infusions, Intravenous
Male
Metalloporphyrins--administration & dosage
Middle Aged
Photochemotherapy--adverse effects
Photosensitizing Agents--administration & dosage
Stents
Treatment Outcome